1:10 PM
Aug 01, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Huntington’s disease (HD)

Mouse studies identified a PPP1R15B inhibitor that could help treat HD. Chemical synthesis and in vitro testing of guanabenz analogs yielded a compound that bound PPP1R15B...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >